Literature DB >> 7510519

Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.

R R Huang1, H Yu, C D Strader, T M Fong.   

Abstract

The neurokinin-1 receptor is a member of the G-protein-coupled receptor family and has the highest affinity for the endogenous peptide transmitter substance P. Previous studies have indicated that several residues in the first and second extracellular segments, and at least part of the transmembrane domain, of the human neurokinin-1 receptor are involved in substance P binding to the receptor. To further map the peptide binding site, single-residue substitutions in the transmembrane domains were analyzed. Asn-85, Asn-89, Tyr-92, and Asn-96 in the second transmembrane domain and Tyr-287 in the seventh transmembrane domain are required for the high-affinity binding of peptides, with Asn-85 possibly interacting with the C-terminus of substance P. In addition, Glu-78 in the second transmembrane domain and Tyr-205 in the fifth transmembrane domain appear to be involved in the receptor activation process. Some of the key residues for peptide binding are likely to be near those residues that are required for the binding of competitive antagonists (such as His-197, His-265, and Tyr-287). These data suggest that a volume exclusion effect can explain the competitive antagonism of substance P binding by non-peptide antagonists. Furthermore, the key residues identified thus far are required for the high-affinity binding of all three neurokinin peptides, consistent with a hypothesis that the conformational compatibility between the receptor and the peptide agonist may be a major determinant of peptide recognition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510519     DOI: 10.1021/bi00176a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Molecular dynamics study of substance P peptides in a biphasic membrane mimic.

Authors:  T Wymore; T C Wong
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

2.  Activation of membrane receptors.

Authors:  T H Ji; W J Murdoch; I Ji
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

Review 3.  Functional domains of the gonadotropin-releasing hormone receptor.

Authors:  S C Sealfon; R P Millar
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

Review 4.  Modes of peptide binding in G protein-coupled receptors.

Authors:  M Berthold; T Bartfai
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

5.  Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.

Authors:  F M Dautzenberg; S Wille; R Lohmann; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor.

Authors:  K Prendergast; K Adams; W J Greenlee; R B Nachbar; A A Patchett; D J Underwood
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

7.  Molecular dynamics study of substance P peptides partitioned in a sodium dodecylsulfate micelle.

Authors:  T Wymore; T C Wong
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

8.  The orientation and dynamics of substance P in lipid environments.

Authors:  D A Keire; M Kobayashi
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

9.  Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor.

Authors:  Morris F Tansky; Charalabos Pothoulakis; Susan E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

10.  Mapping substance P binding sites on the neurokinin-1 receptor using genetic incorporation of a photoreactive amino acid.

Authors:  Louise Valentin-Hansen; Minyoung Park; Thomas Huber; Amy Grunbeck; Saranga Naganathan; Thue W Schwartz; Thomas P Sakmar
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.